Flu in the News / Heart Attacks

Topic: Heart Attacks

Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients

Drugs.com | 4 hours ago

Angiotech Pharmaceuticals, Inc. ("Angiotech") and partner Athersys, Inc. announced positive results from its phase I clinical trial of ...

Athersys, Angiotech gain on stem cell study

MarketWatch | 5 hours ago

Partners Athersys Inc. (ATHX 2.99, +0.23, +8.33%) and Angiotech Pharmaceuticals (ANPI 0.61, -0.01, -1.61%) both gained ground in early Thursday...

Hospitals boost response rates for timely angioplasties

American Medical Association News | 6 hours ago

American hospitals have made extensive improvements in delivering faster heart attack care in the last five years, and the death rate for heart...

Settlement in NYC steampipe blast

Examiner.com: Anchorage, Alaska | 6 hours ago

The man who was caught in a steampipe blast in New York City three years ago has settled his lawsuit against Consolidated Edison.. . Gregory...

In Play (AZN)

MSN Money | 6 hours ago

AstraZeneca: FDA Advisory Committee recommends US FDA approval of Brilinta (Ticagrelor) for acute coronary syndromes . Briefing. com is the leading...